| Literature DB >> 33717074 |
Juliana de Melo Batista Dos Santos1, Camila Pereira Soares2, Fernanda Rodrigues Monteiro3,4, Ralyria Mello2, Jonatas Bussador do Amaral3, Andressa Simões Aguiar5,6, Mariana Pereira Soledade6, Carolina Sucupira6, Milena De Paulis7, Juliana Bannwart Andrade7, Flavia Jaqueline Almeida8, Marco Aurélio Palazzi Sáfadi8, Luciana Becker Mau9, Jamile Menezes Brasil9, Theresa Ramalho10, Flávio V Loures11, Rodolfo Paula Vieira1,12,13, Edison Luiz Durigon2,14, Danielle Bruna Leal de Oliveira2,14, André Luis Lacerda Bachi3,15.
Abstract
Likely as in other viral respiratory diseases, SARS-CoV-2 elicit a local immune response, which includes production and releasing of both cytokines and secretory immunoglobulin (SIgA). Therefore, in this study, we investigated the levels of specific-SIgA for SARS-CoV-2 and cytokines in the airways mucosa 37 patients who were suspected of COVID-19. According to the RT-PCR results, the patients were separated into three groups: negative for COVID-19 and other viruses (NEGS, n = 5); negative for COVID-19 but positive for the presence of other viruses (OTHERS, n = 5); and the positive for COVID-19 (COVID-19, n = 27). Higher specific-SIgA for SARS-CoV-2, IFN-β, and IFN-γ were found in the COVID-19 group than in the other groups. Increased IL-12p70 levels were observed in OTHERS group as compared to COVID-19 group. When the COVID-19 group was sub stratified according to the illness severity, significant differences and correlations were found for the same parameters described above comparing severe COVID-19 to the mild COVID-19 group and other non-COVID-19 groups. For the first time, significant differences are shown in the airway's mucosa immune responses in different groups of patients with or without respiratory SARS-CoV-2 infection.Entities:
Keywords: SARS-CoV-2; cytokine-immunological terms; mucosal immmunity; respiratory; secretory immunoglobulin A; viruses
Mesh:
Substances:
Year: 2021 PMID: 33717074 PMCID: PMC7946815 DOI: 10.3389/fimmu.2021.595343
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561